ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質(癌免疫療法用)

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
SCF-H4212
製品名称
ActiveMax Recombinant Human SCF /KITLG
タンパク質名
SCF
Species
Human
HOST
HEK293
20ug: 42,000円
お問い合わせ
50ug: 74,000円
お問い合わせ
1mg: 462,000円
お問い合わせ

Overview

Synonyms KITLG,FPH2,KL-1,Kitl,MGF,SCF,SF,SHEP7,KL
Characteristics This protein carries no "tag". The protein has a calculated MW of 21 kDa. The protein migrates as 30-42 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level Less than 1.0 EU per μg by the LAL method.
Purity >98% as determined by SDS-PAGE.
Description Stem Cell Factor is also known as SCF, kit-ligand, KL, steel factor, KITLG, FPH2, KL-1, Kitl, MGF, SCF, SF, or SHEP7, and is a cytokine that binds to the c-Kit receptor (CD117). SCF can exist both as a transmembrane protein and a soluble protein. This cytokine plays an important role in hematopoiesis (formation of blood cells), spermatogenesis, and melanogenesis. The soluble and transmembrane forms of the protein are formed by alternative splicing of the same RNA transcript.Soluble and transmembrane SCF is produced by fibroblasts and endothelial cells. Soluble SCF has a molecular weight of 18,5 KDa and forms a dimer. SCF plays an important role in the hematopoiesis during embryonic development. Sites where hematopoiesis takes place, such as the fetal liver and bone marrow, all express SCF. During development, the presence of the SCF also plays an important role in the localization of melanocytes, cells that produce melanin and control pigmentation. SCF plays a role in the regulation of HSCs in the stem cell niche in the bone marrow. SCF may be used along with other cytokines to culture HSCs and hematopoietic progenitors. The expansion of these cells ex-vivo (outside the body) would allow advances in bone-marrow transplantation, in which HSCs are transferred to a patient to re-establish blood formation.
Reference (1) Anderson DM, et al., 1991, Cell Growth Differ. 2 (8): 373?8.
(2) Broudy VC, 1997, Blood 90 (4): 1345?64.
(3) Blouin R, Bernstein A, 1993, In Freedman MH, Feig SA. Boca Raton: CRC Press.
(4) Kent D, et al., 2008, Clin. Cancer Res. 14 (7): 1926?30.
URL http://www.acrobiosystems.com/P257-Human-SCF-KITLG-ProteinHEK293-expressedActiveMax.html

お問い合わせリスト(-)

お問い合わせフォーム